Stock 3151 VITAL KSK HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vital KSK Holdings, Inc.

Equities

3151

JP3778280002

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
1,221 JPY +1.58% Intraday chart for Vital KSK Holdings, Inc. +3.91% +16.95%
Feb. 07 Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024 CI
2023 Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023. CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 59,005 61,540 60,288 43,580 39,310 46,297
Enterprise Value (EV) 1 47,769 36,437 44,831 30,593 24,188 37,516
P/E ratio 15.3 x 14.1 x 15.3 x 37.1 x 8.36 x 9.64 x
Yield 1.91% 1.83% 2.19% 1.52% 3.27% 4.36%
Capitalization / Revenue 0.1 x 0.11 x 0.11 x 0.08 x 0.07 x 0.08 x
EV / Revenue 0.08 x 0.07 x 0.08 x 0.06 x 0.04 x 0.06 x
EV / EBITDA 9.78 x 6.21 x 6.21 x 32.6 x 3.98 x 6.44 x
EV / FCF 6.65 x 2.36 x -4.65 x -5.26 x 3.82 x -3.38 x
FCF Yield 15% 42.4% -21.5% -19% 26.2% -29.6%
Price to Book 0.6 x 0.64 x 0.63 x 0.42 x 0.4 x 0.47 x
Nbr of stocks (in thousands) 56,356 56,356 54,957 55,234 53,483 51,786
Reference price 2 1,047 1,092 1,097 789.0 735.0 894.0
Announcement Date 6/29/18 6/28/19 6/26/20 6/28/21 6/29/22 6/30/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 565,589 559,712 562,505 537,030 577,249 579,772
EBITDA 1 4,884 5,864 7,216 939 6,070 5,824
EBIT 1 2,384 2,822 3,558 -2,259 2,947 2,471
Operating Margin 0.42% 0.5% 0.63% -0.42% 0.51% 0.43%
Earnings before Tax (EBT) 1 6,491 7,687 7,244 2,430 7,647 8,110
Net income 1 4,467 5,084 4,642 1,171 4,770 4,831
Net margin 0.79% 0.91% 0.83% 0.22% 0.83% 0.83%
EPS 2 68.23 77.64 71.56 21.25 87.88 92.69
Free Cash Flow 1 7,182 15,432 -9,650 -5,815 6,328 -11,107
FCF margin 1.27% 2.76% -1.72% -1.08% 1.1% -1.92%
FCF Conversion (EBITDA) 147.06% 263.17% - - 104.25% -
FCF Conversion (Net income) 160.78% 303.54% - - 132.66% -
Dividend per Share 2 20.00 20.00 24.00 12.00 24.00 39.00
Announcement Date 6/29/18 6/28/19 6/26/20 6/28/21 6/29/22 6/30/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 285,519 266,670 285,229 154,100 143,521 289,376 153,814 144,542 294,213 154,696
EBITDA - - - - - - - - - -
EBIT 1 1,436 -1,111 934 1,152 452 730 1,136 1,167 2,868 2,790
Operating Margin 0.5% -0.42% 0.33% 0.75% 0.31% 0.25% 0.74% 0.81% 0.97% 1.8%
Earnings before Tax (EBT) 1 3,650 828 2,280 1,865 1,081 2,350 1,782 1,431 3,536 4,089
Net income 1 2,464 438 1,411 1,037 640 1,437 996 917 2,347 2,707
Net margin 0.86% 0.16% 0.49% 0.67% 0.45% 0.5% 0.65% 0.63% 0.8% 1.75%
EPS 2 43.80 7.980 25.67 19.17 12.05 27.42 19.17 17.81 45.78 53.34
Dividend per Share 11.00 12.00 12.00 - - 12.00 - - 19.00 -
Announcement Date 11/5/19 11/5/20 11/9/21 2/3/22 8/2/22 11/10/22 2/3/23 8/2/23 11/6/23 2/7/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 11,236 25,103 15,457 12,987 15,122 8,781
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 7,182 15,432 -9,651 -5,815 6,328 -11,107
ROE (net income / shareholders' equity) 4.82% 5.3% 4.89% 1.28% 4.79% 4.93%
ROA (Net income/ Total Assets) 0.48% 0.54% 0.7% -0.46% 0.59% 0.51%
Assets 1 940,025 938,873 665,424 -256,742 808,612 954,743
Book Value Per Share 2 1,735 1,704 1,753 1,864 1,855 1,911
Cash Flow per Share 2 502.0 767.0 602.0 539.0 505.0 367.0
Capex 1 7,825 1,607 1,150 3,312 3,415 5,840
Capex / Sales 1.38% 0.29% 0.2% 0.62% 0.59% 1.01%
Announcement Date 6/29/18 6/28/19 6/26/20 6/28/21 6/29/22 6/30/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
VITAL KSK HOLDINGS, INC. Stock Vital KSK Holdings, Inc.
+16.95% 389M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-3.38% 3.93B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 3151 Stock
  4. Financials Vital KSK Holdings, Inc.